The Impact of Cyclosporine on the Development of Immunosuppressive Therapy: Perspective from a Transplant Nephrologist Involved with the Development of C2. Edward Cole MD FRCPC and Rushi Deshpande MD,Transplantation proceedings March 2004
Survival to Discharge Among Patients Treated with Continuous Renal Replacement Therapy Ron Wald, MDCM, Rushi Deshpande, MD, Chaim M. Bell, MD PhD, Joanne M. Bargman, MD.University Health Network , University of Toronto, Toronto, Canada Accepted for Publication in Hemodialysis International
Should kidneys from marginal donors be used as double or single transplants Rushi Deshpande, MD,DM Robert Smith, Carl Cardella,Daniel Cattran, Stanley Fenton and Edward Cole. Renal Transplant Programme, University Health Network,University of Toronto, Toronto, Ontario, Canada.Oral paper presentation at the American Transplant Congress May 2004,Boston USA
Extended Criteria Donor Kidneys Selected on Pathologic and Functional Criteria Have Excellent 5 Year Survival Rushi Deshpande, MD,DM , Robert Smith, Ali Alobaidli, Carl Cardella, Daniel Cattran, Stanley Fenton and Edward Cole. Renal Transplant Programme, University Health Network,University of Toronto, Toronto, Ontario, Canada.Accepted for poster presentation at American society of Nephrology Renal week 2005
Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Rushi Deshpande and his staff know how they are doing and how they can improve their services.
How was your experience with Dr. Rushi Deshpande?
Help other patients, and let the doctor know how he's doing